An open clinical trial was carried out to compare the efficacy and the tolerability of 1 g/day α-
glycerylphosphorylcholine (α-GPC) with 1 g/day cytosine diphosphocholine (CDP) both …

A multicenter, unblinded, randomized, controlled clinical trial was conducted to evaluate the
efficacy and tolerability of L-α-glycerylphosphorylcholine (L-α-GPC) 1 gm/day IM compared …

The efficacy of cytidine diphosphate choline (CDP-choline) on chronic cerebrovascular
disease was evaluated in a multicentre, double-blind, placebo-controlled clinical trial …

The neuroprotective glial cell modulator propentofylline has been used in clinical trials
involving more than 800 patients with vascular dementia (VaD). These data derive from two …

The clinical efficacy and the tolerability of alpha-glycerophosphocholine (alpha-GPC), a
drug able to provide high levels of choline for the nervous cells of the brain and to protect …

The clinical efficacy and the tolerability of alpha-glycerophosphocholine (alpha-GPC), a
drug able to provide high levels of choline for the nervous cells of the brain and to protect …

Pathophysiotogic processes common to both vascular (multi-infarct) dementia and dementia
of the Alzheimer type may include microglial activation with resultant generation of …

A multicentre, randomised, controlled study compared the efficacy of l-α-glyceryl-
phosphorylcholine (α GPC) and ST200 (acetyl-l-carnitine) among 126 patients with probable …

This paper has reviewed the documentation on the clinical efficacy of choline alphoscerate,
a cholinergic precursor, considered as a centrally acting parasympathomimetic drug in …

This systematic review seeks to (1) summarize the pharmacologic effects of pentoxifylline on
the cerebrovasculature and (2) review critically the studies evaluating pentoxifylline in the …